Complete Filing Data
XChange TEC.INC reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $2.23 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean XChange TEC.INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$105.1M | -$226.8M | -$71.3M | $820.0M | -$569.2M | -$1.53B | -$498.2M | -$499.9M |
| Revenue * | $365.3M | $288.4M | $79.5M | $939.2M | $1.11B | $1.09B | $796.9M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$22.1M | $99.7M | -$4.0M | -$9.3M | $20.4M | $24.3M | -$7.6M | $4.6M |
| Operating Income Loss | -$720.3M | -$588.8M | -$23.5M | -$29.4M | -$27.3M | -$1.50B | -$448.3M | -$426.4M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$748.4M | -$612.6M | -$25.1M | -$495.1M | -$130.6M | -$1.53B | -$498.3M | -$497.5M |
| General And Administrative Expense | $4.6M | $16.1M | $23.5M | $29.3M | $27.5M | $102.8M | $108.2M | $85.0M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$18.1M | -$75.3M | $810.6M | -$548.8M | -$1.51B | -$506.0M | -$495.4M | |
| Selling And Marketing Expense | $9.9M | $11.2M | $24.0K | $12.0K | $7.0K | $63.5M | $135.4M | $117.8M |
| Research And Development Expense | $24.0K | $46.0K | $22.0K | $7.8M | $24.9M | $47.0M | $51.9M | |
| Income Tax Expense Benefit | $46.0K | $548.0K | $3.0K | $31.0K | $13.0K | $63.0K | $2.4M | |
| Comprehensive Income Net Of Tax | -$770.5M | -$127.1M | -$75.3M | $810.7M | -$548.7M | -$1.51B | -$505.9M | -$495.3M |
| Cost Of Revenue | $357.3M | $274.9M | $100.0M | $949.7M | $1.20B | $1.30B | $898.0M | |
| Asset Impairment Charges | $100.2M | $199.6M | $846.8M | $46.2M | $50.6M | |||
| Net Income Loss Attributable To Noncontrolling Interest | -$43.0K | -$28.0K | -$49.0K | -$95.0K | -$63.0K | |||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$43.0K | -$28.0K | -$49.0K | -$95.0K | -$63.0K | |||
| Deferred Revenue Current | $18.3M | $171.2M | $152.6M | $78.5M | ||||
| Interest Income Expense Nonoperating Net | -$9.4M | -$127.3M | -$130.2M | -$91.9M | -$77.2M | |||
| Net Income Loss Available To Common Stockholders Basic | -$105.1M | -$226.8M | -$71.3M | $820.0M | -$569.2M | -$1.53B | -$805.6M | -$635.4M |
| Income Loss From Continuing Operations Per Diluted Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Income Loss From Continuing Operations Per Basic Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$880.1M | -$556.6M | -$643.4M | -$572.9M | -$2.49B | -$2.00B | -$2.25B | -$1.42B | -$794.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.2M | $13.1M | $286.0K | $556.0K | $1.4M | $31.8M | $250.8M | $118.8M | $367.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $392.0K | $12.0M | -$1.8M | -$16.4M | -$12.5M | -$219.0M | $132.1M | -$248.4M | |
| Cash And Cash Equivalents At Carrying Value | $1.5M | $8.1M | $286.0K | $563.0K | $16.3M | $22.9M | $159.8M | $103.8M | |
| Retained Earnings Accumulated Deficit | -$646.9M | -$3.86B | -$3.63B | -$3.56B | -$4.38B | -$3.81B | -$2.28B | ||
| Liabilities And Stockholders Equity | $69.4M | $782.8M | $85.7M | $95.5M | $377.6M | $850.7M | $1.80B | ||
| Liabilities | $133.4M | $1.34B | $729.1M | $668.4M | $2.86B | $2.85B | $2.61B | ||
| Assets Current | $5.6M | $67.6M | $85.7M | $71.2M | $176.7M | $203.0M | $596.5M | ||
| Assets | $9.7M | $782.8M | $85.7M | $95.5M | $377.6M | $850.7M | $1.80B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $80.0M | $106.0M | $25.4M | $29.5M | $38.8M | $18.4M | -$5.9M | ||
| Other Assets Current | $146.0K | $7.5M | $282.0K | $59.0M | $143.3M | $101.8M | $146.6M | ||
| Accounts Payable Current | $4.1M | $37.0M | $182.0K | $122.7M | $320.3M | $294.5M | $277.1M | ||
| Liabilities Current | $949.2M | $1.34B | $729.1M | $94.0M | $2.35B | $1.96B | $1.70B | ||
| Assets Noncurrent | $29.5M | $715.2M | $24.4M | $201.0M | $647.7M | $1.20B | |||
| Property Plant And Equipment Net | $6.0K | $6.0K | $500.0K | $38.9M | $358.0M | $1.19B | |||
| Accounts Receivable Net Current | $23.5M | $36.3M | $106.0K | $370.0K | $1.9M | $1.3M | |||
| Asset Acquisition Contingent Consideration Liability Current | $165.2M | $162.8M | $169.3M | $165.0M | $169.3M | ||||
| Liabilities Noncurrent | $353.0K | $587.0K | $514.9M | $883.4M | $913.5M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.2M | $1.8M | $1.1M | $2.9M | $19.3M | $31.8M | |||
| Other Assets Noncurrent | $10.4M | $9.6M | $57.1M | $5.9M | |||||
| Intangible Assets Net Excluding Goodwill | $678.0K | $1.9M | $152.5M | $222.1M | $1.2M | ||||
| Deposit Liability Current | $5.4M | $65.8M | $82.2M | $163.2M | |||||
| Restricted Cash Current | $15.0K | $2.9M | $8.9M | $91.0M | $15.0M | ||||
| Repayment Of Long Term Bank Debt | $37.1M | $122.5M | $49.1M | $108.1M | |||||
| Debt Current | $110.1M | $558.7M | $762.1M | $319.1M | |||||
| Advances On Inventory Purchases | $8.5M | $12.9M | $16.0M | $64.0M | |||||
| Accrued Expenses And Other Current Liabilities | $11.5M | $1.05B | $443.4M | $99.3M | |||||
| Repayment Of Short Term Bank Debt | $4.5M | $65.0M | $79.0M | $49.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $2.6M | $8.7M | $37.9M | $34.1M | $101.6M | -$134.9M | $569.6M | $539.5M |
| Investing Cash Flow * | -$69.0K | $10.2M | -$11.5M | -$6.5M | -$138.7M | -$351.5M | -$674.3M | |
| Operating Cash Flow * | -$11.7M | -$9.8M | -$39.9M | -$44.3M | -$109.7M | $54.8M | -$88.2M | -$117.0M |
| Share Based Compensation | $2.5M | $4.8M | $9.8M | $15.8M | $16.0M | $8.2M | $2.3M | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $36.0K | $388.0K | -$2.2M | $53.9M | -$48.6M | $269.5M | -$4.0M | $36.2M |
| Increase Decrease In Other Current Assets | -$6.8M | $6.2M | $282.0K | -$6.5M | -$23.5M | -$44.8M | -$2.0M | $21.5M |
| Proceeds From Convertible Debt | $20.0M | $113.2M | $24.0M | |||||
| Increase Decrease In Accounts Receivable | -$13.0M | $16.9M | $391.0K | -$1.6M | $644.0K | $831.0K | $160.0K | |
| Proceeds From Short Term Bank Debt | $6.5M | $39.7M | $351.0M | $84.0M | $100.0M | |||
| Increase Decrease In Security Deposits | -$3.6M | -$16.4M | -$161.5M | $49.9M | $32.2M | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$33.0K | -$37.6M | -$146.9M | -$49.8M | $75.9M | |||
| Increase Decrease In Other Noncurrent Assets | $849.0K | -$47.6M | $51.2M | $5.6M | $188.0K | |||
| Increase Decrease In Due From Related Parties Current | -$28.0K | $33.0K | -$5.4M | -$8.9M | $10.0M | |||
| Increase Decrease In Deferred Revenue | -$5.7M | -$18.6M | -$127.9M | $17.5M | $22.2M | |||
| Proceeds From Long Term Bank Debt | $5.2M | $6.5M | $39.7M | $150.0M | $170.0M | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $31.0K | $5.4M | $2.0M | -$295.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$1.14 | -$1.87 | -$1.55 |
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.14 | ||
| Weighted Average Number Of Shares Outstanding Basic | 50.25B | 238.2M | 28.1M | 1.03T | 146.07B | 1.35B | ||
| Weighted Average Number Of Diluted Shares Outstanding | 50.25B | 238.2M | 28.1M | 1.03T | 146.07B | 1.35B |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Other Operating Income Expense Net | -$1.1M | -$18.5M | $15.9M | $2.4M | $4.0M | |||
| Costs And Expenses | $896.2M | $1.44B | $2.71B | $1.68B | $1.32B | |||
| Accretion Expense | $27.5M | $24.0M | $1.2M | $2.0M | $214.0K | $15.8M | $10.7M | |
| Foreign Currency Transaction Gain Loss Before Tax | -$70.0K | $2.3M | -$244.0K | -$62.0K | -$457.0K | -$91.0K | ||
| Repayments Of Lines Of Credit | $2.0M | $85.0M | $924.2M | $1.44B | $1.52B | |||
| Depreciation And Amortization | $54.0K | $3.9M | $79.3M | $263.0M | $215.1M | $152.3M | ||
| Other Income | $86.6M | $97.0M | $102.8M | $144.6M | $93.0M | |||
| Interest Paid Net | $1.0M | $16.6M | $79.6M | $68.6M | ||||
| Rental Installment Loans | $2.2M | $18.1M | $54.5M | $756.7M | ||||
| Short Term Borrowings | $4.6M | $32.1M | $44.4M | $6.5M | ||||
| Prepaid Expense Current | $571.0K | $51.3M | $128.2M |
Most recent annual filing with the SEC: January 14, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.